Barry FitzGerald says investors are rotating into unloved explorers Canterbury and Cygnus hoping to get in early on new ...

Neuren’s NNZ-2591 receives a Rare Pediatric Disease Designation from US FDA. Neuren is also preparing for a key FDA meeting.

The global graphite deficit is expected to continue beyond 2030, with the US looking to Australia, not China, to meet its ...

Sustainable buildings help reduce carbon emissions. Ethical investors can back this theme via green bonds and sustainability ...

Fortescue’s 15Mtpa hydrogen by 2030 ambition is no longer achievable, but its efforts could still be a positive for renewable ...

Whitehaven Coal is aiming to ramp up met coal sales, three months after securing BHP's Daunia and Blackwater mines in a major ...

Orthocell (ASX:OCC) is among ASX companies leading Western Australia's push to grow its health and medical life sciences ...

Experts express skepticism about AI's cost-effectiveness. Despite differing views, Goldman Sachs analysts remain optimistic ...

Flynn Gold discovers new zone of mineralisation across 2.5km-long strike at Golden Ridge and Argosy scores 20t sale of ...

Investors are favouring small caps amid expectations of an imminent Fed rate cut and the “Trump Trade” is also gaining ...

Good morning everyone, and welcome to 19 July, 2024 – an important date for a couple of groovy reasons. For starters, it was ...

New research finds that taking a break from the couch-potato life to do simple exercises before bed can help you sleep about ...